 |
市場調查報告書
商品編碼
2050639
注射市場：依分子類型、給藥途徑、治療領域、藥物類別、通路和地區分類Injectable Drugs Market, By Molecule Type, By Route of Administration, By Therapeutic Area, By Drug Class, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計到2026年，注射劑市場規模將達到6,625.8億美元，到2033年將達到1.12821兆美元。預計從2026年到2033年，其複合年成長率將達到7.9%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 6625.8億美元 |
| 歷史數據時期： | 2020-2024 | 預測期： | 2026-2033 |
| 2026年至2033年預測期間的複合年成長率： | 7.90% | 2033年市場規模預測： | 11282.1億美元 |
注射劑是指直接注射到體內的藥物，主要透過靜脈、肌肉或組織注射。由於注射劑能將藥物直接輸送到血液中，確保快速起效，因此在各種重症監護環境中，注射劑優於其他給藥方式。藥物傳遞技術的進步推動了新型注射劑製劑的研發，提高了活性成分的穩定性、溶解度和生物利用度。慢性病盛行率的上升、人們對生物製藥和標靶藥物療法的興趣日益濃厚，以及對可自行注射藥物的需求不斷成長，都可能推動市場成長。
市場動態
全球注射劑市場的成長主要受癌症、糖尿病和自體免疫疾病等慢性病盛行率上升的推動。根據世界衛生組織估計，慢性病導致的死亡人數佔全球死亡總數的60%以上。生物製藥和標靶藥物療法在癌症和自體免疫疾病治療的快速應用也可能促進市場成長。然而，注射劑產品研發和生產的高成本可能對市場相關人員構成挑戰。注射過程中針刺傷的風險也可能阻礙其廣泛應用。對自行注射製劑的需求不斷成長，尤其是在慢性病管理方面，這可能在不久的將來帶來成長機會。
本研究的關鍵特徵
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數，對全球注射劑市場中主要的公司進行概況分析。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
- 全球注射劑市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以利用各種用於分析全球注射劑市場的策略矩陣，更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 併購情景
第4章 全球注射劑市場：依分子類型分類，2021-2033年
- 低分子
- 聚合物
第5章 全球注射劑市場：依給藥途徑分類，2021-2033年
- 靜脈
- 肌肉內部
- 皮下
- 其他（皮內注射等）
第6章 全球注射劑市場：依治療領域分類，2021-2033年
- 腫瘤學
- 感染疾病
- 自體免疫疾病
- 心血管疾病
- 內分泌學
- 神經病學
- 其他（呼吸內科、血液科等）
第7章 全球注射劑市場：依藥物類別分類，2021-2033年
- 單株抗體
- 胜肽和蛋白質
- 小分子藥物
- 免疫球蛋白
- 荷爾蒙
- 其他（疫苗、生技藥品等）
第8章 全球注射劑市場：依通路分類，2021-2033年
- 醫院藥房
- 零售藥房
- 網路藥房
第9章 全球注射劑市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第10章 競爭格局
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- AstraZeneca Plc
- Merck & Co., Inc.
- Viatris+Mylan NV
- Cipla Inc.
- Dr Reddy's Laboratories Ltd.
- Samsung Biologics
- Abbott Laboratories
- Amgen Incorporated
- Baxter International Incorporated
- Becton Dickinson and Company
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Roche Holding Limited
第11章 分析師建議
- 機會分析
- 一致的機會地圖
第12章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI5378
Injectable Drugs Market is estimated to be valued at USD 662.58 Bn in 2026 and is expected to reach USD 1,128.21 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 662.58 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.90% | 2033 Value Projection: | USD 1,128.21 Bn |
Injectable drugs refer to medications that are administered directly into the body, mostly through veins, muscles or tissues. These are preferred over other drug delivery methods for various critical care therapies, owing to their ability to deliver medications directly into the bloodstream, ensuring rapid onset of action. Advancements in drug delivery technologies have led to development of novel injectable formulations with improved stability, solubility and bioavailability of active pharmaceutical ingredients. Growing prevalence of chronic diseases, rising focus on biologics and targeted drug therapies, and increasing demand for self-administered injectables can drive the market growth.
Market Dynamics
Global injectable drugs market growth is driven by rising prevalence of chronic diseases such as cancer, diabetes and autoimmune disorders. According to WHO, chronic diseases are estimated to account for over 60% of global deaths. Rapid adoption of biologics and targeted drug therapies for treatment of cancer and autoimmune diseases can also drive the market growth. However, high costs associated with R&D and manufacturing of injectable products can pose challenges for the market players. Risk of needle-stick injuries while administering injectables can also hamper its adoption. Growing demand for self-administered injectables especially for management of chronic diseases can offer growth opportunities in the near future.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global injectable drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Pfizer, Novartis, Sanofi, GlaxoSmithKline, Gilead Sciences and AbbVie.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drugs market.
Market Segmentation
- By Molecule Type Insights (Revenue, USD Bn, 2021 - 2033)
- Small Molecule
- Large Molecule
- By Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Intravenous
- Intramuscular
- Subcutaneous
- Others (Intradermal etc.)
- By Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Infectious Diseases
- Autoimmune Disorders
- Cardiovascular Diseases
- Endocrinology
- Neurology
- Others (Respiratory, Hematology, etc.)
- By Drug Class Insights (Revenue, USD Bn, 2021 - 2033)
- Monoclonal Antibodies
- Peptides and Proteins
- Small Molecules
- Immunoglobulins
- Hormones
- Others (Vaccines, Biologics, etc.)
- By Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- AstraZeneca Plc
- Merck & Co., Inc.
- Viatris + Mylan N.V
- Cipla Inc.
- Dr Reddy's Laboratories Ltd.
- Samsung Biologics
- Abbott Laboratories
- Amgen Incorporated
- Baxter International Incorporated
- Becton Dickinson and Company
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Roche Holding Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Injectable Drugs Market, By Molecule Type
- Global Injectable Drugs Market, By Route of Administration
- Global Injectable Drugs Market, By Therapeutic Area
- Global Injectable Drugs Market, By Drug Class
- Global Injectable Drugs Market, By Distribution Channel
- Global Injectable Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Injectable Drugs Market, By Molecule Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Large Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Injectable Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Intradermal etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Injectable Drugs Market, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Respiratory, Hematology, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Injectable Drugs Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Peptides and Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Small Molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunoglobulins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Vaccines, Biologics, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Injectable Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Injectable Drugs Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2021 - 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris + Mylan N.V
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dr Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Samsung Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Holding Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
全球注射用胜肽類藥物市場：依藥物類別、給藥途徑、劑型、遞送系統、治療領域、通路及最終用戶分類－市場規模、產業趨勢、機會分析及2026-2035年預測
葡萄糖注射劑市場：依產品類型、應用、通路和地區分類
緩釋注射劑市場：按產品類型、聚合物類型、給藥途徑、應用和最終用戶分類 - 全球市場預測（2026-2032 年）Ketorolac酸注射劑市場報告：趨勢、預測和競爭分析（至2035年）非專利抗癌無菌注射市場：依產品類型、疾病、通路及地區分類。注射市場：2026年至2032年全球市場預測（依藥物類別、分子類型、分類、給藥途徑、治療應用及最終用戶分類）肌注藥物稀釋劑市場：依產品類型、稀釋劑類型、最終用戶、通路和應用分類－2026-2032年全球市場預測長效注射藥物市場：依適應症、分子類型、給藥途徑、器械形式、製劑技術、病患類型、最終用戶、分銷管道、支付方和地區分類。頭孢他啶阿維巴坦市場：按類型、適應症、劑型、藥物類型、最終用戶、分銷管道和地區分類聯合注射藥物市場：按分子類型、治療應用、產品類型、包裝、給藥途徑、年齡層、分銷管道、最終用戶和地區分類
▼